BACKGROUND: Bioprostheses are widely used as an aortic valve substitute,
but knowledge about prognosis is still incomplete. The purpose of this
study was to provide insight into the age-related life expectancy and
actual risks of reoperation and valve-related events of patients after
aortic valve replacement with a porcine bioprosthesis. METHODS AND
RESULTS: We conducted a meta-analysis of 9 selected reports on stented
porcine bioprostheses, including 5837 patients with a total follow-up of
31 874 patient-years. The annual rates of valve thrombosis,
thromboembolism, hemorrhage, and nonstructural dysfunction were 0.03%,
0.87%, 0.38%, and 0.38%, respectively. The annual rate of endocarditis was
estimated at 0.68% for >6 months of implantat